Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical Data In 2014 Could Trigger Private Biotech Financings

This article was originally published in Start Up

Executive Summary

Despite difficulties financing late-stage trials, several private companies are expecting Phase II and III data that should help shape public investor sentiment this year. Familiar compounds in new guises lead the way.


Related Content

AZ Doubles Down On Diabetes, Buys Out Bristol’s Share in Alliance
Russian, Korean Pharmas Lead $42.5M Argos Financing, Take Local Rights
CROs And Biopharma Weigh The Balance Of Risk And Responsibility
Adynxx Inc.
Intarcia Forgoes Partnerships, Raises $210M In Equity And Debt Instead


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts